Results 141 to 150 of about 5,800 (169)
Some of the next articles are maybe not open access.
Managing Patients with Vulvovaginal Candidiasis
The Nurse Practitioner, 1998Epidemiologic studies have demonstrated a continuing increase in the prevalence of vulvovaginal candidiasis. Although in the past most of these infections were caused by Candida albicans, an increasing percentage are caused by non-albicans Candida species that are less sensitive to the most frequently used antifungal agents.
openaire +2 more sources
BMJ clinical evidence, 2018
Vulvovaginal candidiasis is estimated to be the second most common cause of vaginitis after bacterial vaginosis. Candida albicans accounts for 85% to 90% of cases.We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of drug treatments for acute vulvovaginal candidiasis in non-pregnant symptomatic ...
openaire +1 more source
Vulvovaginal candidiasis is estimated to be the second most common cause of vaginitis after bacterial vaginosis. Candida albicans accounts for 85% to 90% of cases.We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of drug treatments for acute vulvovaginal candidiasis in non-pregnant symptomatic ...
openaire +1 more source
Pathogenesis of recurrent vulvovaginal candidiasis
Current Infectious Disease Reports, 2002Recurrent vulvovaginal candidiasis (RVVC) is by no means uncommon and is a source of considerable physical suffering, in addition to serving as a major therapeutic challenge. The syndrome is multifactorial in etiology, hence management strategies must recognize the complex etiologic pathways. Considerable progress has been made in identifying secondary
openaire +2 more sources
Classification and pathogenesis of vulvovaginal candidiasis
American Journal of Obstetrics and Gynecology, 1985Although candidiasis of the female genital tract is one of the most common of the vaginitides, it is a poorly understood disease entity. Vulvovaginal candidiasis is a monoetiologic disease, but the pathways by which pathogenic expression is attained are sufficiently divergent to constitute a classification schema that influences therapy.
openaire +2 more sources
Treatment of Vulvovaginal Candidiasis—An Overview of Guidelines and the Latest Treatment Methods
Journal of Clinical Medicine, 2023Krzysztof Kułak +2 more
exaly
Oral Ibrexafungerp: an investigational agent for the treatment of vulvovaginal candidiasis
Expert Opinion on Investigational Drugs, 2020Jack Sobel, David Angulo
exaly